{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:42:03Z","timestamp":1788392523728,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.mayocp.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T06:41:27Z","timestamp":1667457687000},"page":"2355-2368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Skin Cancer in Solid Organ Transplant Recipients: A Review for the Nondermatologist"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-1821","authenticated-orcid":false,"given":"Hannah","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9146-0480","authenticated-orcid":false,"given":"Serena","family":"Shimshak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-4819","authenticated-orcid":false,"given":"Tara","family":"Brigham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-916X","authenticated-orcid":false,"given":"Mary S.","family":"Hedges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Degesys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Tolaymat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib1","first-page":"662","article-title":"Cutaneous complications of immunosuppression in 812 transplant recipients: a 40-year single center experience","volume":"155","author":"Infusino","year":"2020","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000002641","article-title":"Interventions to prevent nonmelanoma skin cancers in recipients of a solid organ transplant: systematic review of randomized controlled trials","volume":"103","author":"Chung","year":"2019","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/abd1806-4841.20164891","article-title":"Non-melanoma skin cancer in Portuguese kidney transplant recipients\u2014incidence and risk factors","volume":"91","author":"Pinho","year":"2016","journal-title":"An Bras Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.suronc.2015.09.007","article-title":"Rising incidence and aggressive nature of cutaneous malignancies after transplantation: an update on epidemiology, risk factors, management and surveillance","volume":"24","author":"Tufaro","year":"2015","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2012.09.030","article-title":"Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation","volume":"68","author":"Gogia","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40257-018-0355-8","article-title":"Skin cancer following solid organ transplantation: a review of risk factors and models of care","volume":"19","author":"Howard","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.mayocp.2022.07.004_bib8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/tri.13011","article-title":"Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study","volume":"30","author":"Fattouh","year":"2017","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib10","first-page":"1099","article-title":"The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"Fuchs","year":"2007","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1203475415583414","article-title":"Non-melanoma skin cancer in Canada chapter 3: management of actinic keratoses","volume":"19","author":"Poulin","year":"2015","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0025-6196(11)64218-3","article-title":"Overview of skin cancer detection and prevention for the primary care physician","volume":"75","author":"Bruce","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaad.2015.04.037","article-title":"Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy","volume":"73","author":"Manyam","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mayocp.2022.07.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104562","article-title":"Cutaneous squamous cell carcinoma in the organ transplant recipient","volume":"103","author":"Bibee","year":"2020","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.6002\/ect.2018.0238","article-title":"Type of organ transplanted impacts the risk and presentation of cutaneous squamous cell carcinoma in transplant recipients","volume":"18","author":"Puza","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women\u2019s Hospital Tumor Staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/DSS.0000000000001774","article-title":"Stratification of poor outcomes for cutaneous squamous cell carcinoma in immunosuppressed patients using the American Joint Committee on Cancer Eighth Edition and Brigham and Women\u2019s Hospital staging systems","volume":"45","author":"Blechman","year":"2019","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2020.12.015","article-title":"A\u00a0multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant","volume":"100","author":"Murakami","year":"2021","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mayocp.2022.07.004_bib23","doi-asserted-by":"crossref","DOI":"10.6002\/ect.2019.0293","article-title":"Vismodegib experience in a renal transplant patient with basal cell carcinoma","author":"Rahatli","year":"2020","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamadermatol.2014.1894","article-title":"Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient","volume":"151","author":"Cusack","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib25","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/jdv.14430","article-title":"Vismodegib for recurrent locally destructive basal cell carcinoma in a renal transplant patient","volume":"32","author":"Koelblinger","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib26","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","article-title":"Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial","volume":"22","author":"Stratigos","year":"2021","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14737140.2022.2043748","article-title":"Cemiplimab for locally advanced and metastatic basal cell carcinoma","volume":"22","author":"Damsin","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/ajt.12716","article-title":"Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study","volume":"14","author":"Vajdic","year":"2014","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamadermatol.2020.1730","article-title":"Consensus, controversy, and conversations about gene expression profiling in melanoma","volume":"156","author":"Chan","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2019.08.059","article-title":"Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision","volume":"82","author":"Hanson","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1600-6143.2010.03078.x","article-title":"Melanoma in solid organ transplant recipients","volume":"10","author":"Zwald","year":"2010","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.mayocp.2022.07.004_bib32","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/ajt.14382","article-title":"Skin cancers in organ transplant recipients","volume":"17","author":"Mittal","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mayocp.2022.07.004_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2021.01.038","article-title":"Transplant rejections associated with immune checkpoint inhibitors: a pharmacovigilance study and systematic literature review","volume":"148","author":"Nguyen","year":"2021","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1634\/theoncologist.2019-0659","article-title":"The safety and efficacy of checkpoint inhibitors in transplant recipients: a case series and systematic review of literature","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"issue":"suppl 7","key":"10.1016\/j.mayocp.2022.07.004_bib35","doi-asserted-by":"crossref","first-page":"vii81","DOI":"10.1093\/annonc\/mdq366","article-title":"Merkel cell carcinoma","volume":"21","author":"Becker","year":"2010","journal-title":"Ann Oncol"},{"issue":"5866","key":"10.1016\/j.mayocp.2022.07.004_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3892\/mco.2017.1406","article-title":"Interaction between Merkel cell carcinoma and the immune system: pathogenetic and therapeutic implications","volume":"7","author":"Zanetti","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.07.004_bib38","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1634\/theoncologist.2020-0184","article-title":"FDA accelerated approval of pembrolizumab for recurrent locally advanced or metastatic Merkel cell carcinoma","volume":"25","author":"Bradford","year":"2020","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1053\/j.ackd.2016.08.002","article-title":"The bad and the good news on cancer immunotherapy: implications for organ transplant recipients","volume":"23","author":"Maggiore","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2019.03.028","article-title":"Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study","volume":"81","author":"Delyon","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1399-3062.2011.00714.x","article-title":"Post renal transplantation Kaposi\u2019s sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy","volume":"14","author":"Hosseini-Moghaddam","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/rmv.583","article-title":"New approaches to the treatment of human herpesvirus 8\u2013associated disease","volume":"18","author":"Casper","year":"2008","journal-title":"Rev Med Virol"},{"issue":"12","key":"10.1016\/j.mayocp.2022.07.004_bib43","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13520","article-title":"Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines","volume":"32","author":"Crow","year":"2019","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/ajt.14966","article-title":"Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamadermatol.2017.5801","article-title":"Prevalence and types of genital lesions in organ transplant recipients","volume":"154","author":"Nadhan","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2012.11213.x","article-title":"Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients","volume":"168","author":"Mihalis","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029265","article-title":"Behavioural and pharmaceutical interventions for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomised controlled trials","volume":"10","author":"James","year":"2020","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib49","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaad.2016.06.031","article-title":"A\u00a0qualitative systematic review of the efficacy of sun protection education in organ transplant recipients","volume":"75","author":"Wu","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2022.07.004_bib50","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1111\/ajt.13863","article-title":"Azathioprine and risk of skin cancer in organ transplant recipients: systematic review and meta-analysis","volume":"16","author":"Jiyad","year":"2016","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2013.04.003","article-title":"Immunosuppression minimization vs. complete drug withdrawal in liver transplantation","volume":"59","author":"Londo\u00f1o","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib52","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/0886022X.2020.1785499","article-title":"The impact of switching to mTOR inhibitor\u2013based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients","volume":"42","author":"Murray","year":"2020","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.mayocp.2022.07.004_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/TP.0b013e3182247ae2","article-title":"Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor\u2013free immunotherapy: 24-month results from the CONVERT trial","volume":"92","author":"Alber\u00fa","year":"2011","journal-title":"Transplantation"},{"issue":"25","key":"10.1016\/j.mayocp.2022.07.004_bib54","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results","volume":"36","author":"Dantal","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaad.2017.12.063","article-title":"Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients","volume":"79","author":"Funk-Debleds","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2015.5548","article-title":"Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer","volume":"152","author":"Karia","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib57","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cam4.487","article-title":"Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis","volume":"4","author":"Yanik","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.mayocp.2022.07.004_bib58","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib60","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.7314\/APJCP.2012.13.9.4335","article-title":"Sirolimus and non-melanoma skin cancer prevention after kidney transplantation: a meta-analysis","volume":"13","author":"Gu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ijd.14549","article-title":"Mammalian target of rapamycin (mTOR) inhibitors and skin cancer risk in nonrenal solid organ transplant recipients: systematic review and meta-analysis","volume":"59","author":"Phan","year":"2020","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.07.004_bib62","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2215\/CJN.00190116","article-title":"Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients","volume":"11","author":"Badve","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib63","first-page":"480","article-title":"Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients","volume":"12","author":"Alter","year":"2014","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"10","key":"10.1016\/j.mayocp.2022.07.004_bib64","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.07.004_bib65","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.mayocp.2022.07.004_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.12659\/AOT.902523","article-title":"Real-world multicenter experience of immunosuppression minimization among 661 liver transplant recipients","volume":"22","author":"Aguiar","year":"2017","journal-title":"Ann Transplant"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib67","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.mayocp.2022.07.004_bib68","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.healun.2012.05.003","article-title":"Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole","volume":"31","author":"Feist","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjd.17148","article-title":"Local interventions for actinic keratosis in organ transplant recipients: a systematic review","volume":"180","author":"Heppt","year":"2019","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.07.004_bib70","first-page":"685","article-title":"Chemowraps as an adjuvant to surgery for patients with diffuse squamous cell carcinoma of the extremities","volume":"7","author":"Mann","year":"2008","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib71","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMoa2024040","article-title":"Phase 3 trials of tirbanibulin ointment for actinic keratosis","volume":"384","author":"Blauvelt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2006.06.006","article-title":"Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus","volume":"56","author":"Braathen","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib73","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jdv.15852","article-title":"Photodynamic therapy for the prevention and treatment of actinic keratosis\/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis","volume":"34","author":"Liew","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib74","first-page":"783","article-title":"A\u00a0synthesis of the world\u2019s guidelines on photodynamic therapy for non-melanoma skin cancer","volume":"153","author":"Morton","year":"2018","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.mayocp.2022.07.004_bib75","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/jdv.16125","article-title":"Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy-controlled randomized clinical trial","volume":"34","author":"Bernad","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib76","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients\u2014a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.07.004_bib77","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaad.2020.04.160","article-title":"Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: systematic review and meta-analyses","volume":"84","author":"Tee","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.mayocp.2022.07.004_bib78","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/DSS.0000000000002072","article-title":"Use of topical and systemic retinoids in solid organ transplant recipients","volume":"45","author":"Herold","year":"2019","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2017.3025","article-title":"Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study","volume":"27","author":"Drago","year":"2017","journal-title":"Eur J Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.07.004_bib80","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib81","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib82","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2022.07.004_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37796\/2211-8039.1110","article-title":"A\u00a0systematic review and meta-analysis: evaluation of the \u03b2-human papillomavirus in immunosuppressed individuals with cutaneous squamous cell carcinoma","volume":"10","author":"Ramezani","year":"2020","journal-title":"Biomedicine (Taipei)"},{"issue":"7","key":"10.1016\/j.mayocp.2022.07.004_bib84","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/597308","article-title":"Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types","volume":"199","author":"Herrero","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2022.07.004_bib85","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00262-020-02644-2","article-title":"Impact of corticosteroids on allograft protection in renal transplant patients receiving anti-PD-1 immunotherapy","volume":"69","author":"Danesh","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.mayocp.2022.07.004_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.healun.2018.09.009","article-title":"Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: a randomized, controlled pilot trial","volume":"38","author":"Miura","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.mayocp.2022.07.004_bib87","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09546634.2019.1687820","article-title":"Efficacy of new class I medical device for actinic keratoses: a randomized controlled prospective study","volume":"32","author":"Veronese","year":"2021","journal-title":"J\u00a0Dermatolog Treat"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622004335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622004335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T21:17:52Z","timestamp":1727385472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622004335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0025619622004335"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.07.004","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin Cancer in Solid Organ Transplant Recipients: A Review for the Nondermatologist","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}